Science Explorer Back to mapMap
Discussion
Researcher · Uppsala University · Sweden

Per Andersson

Per Andersson publishes mostly in Hematology, Pulmonary and Respiratory Medicine and Genetics, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Quinazolinone synthesis and applications.

OpenAlex
World rank
#4,870,603
of 7,710,434 ranked researchers
Rank in Sweden
#56,517
of 71,437
Works
15
Citations
46
Citations per work
3.1
h-index
4
i10-index 2Top 93% in Hematology
Per Andersson

What does Per Andersson research?

Per Andersson's work is mostly in Medicine (57%), Chemistry (11%), Pharmacology, Toxicology and Pharmaceutics (7%).

Health Sciences: 9 works · 56.8% of their workMedicine: 9 works · 56.8% of their workHematology: 4 works · 25.0% of their workPulmonary and Respiratory Medicine: 2 works · 13.6% of their workGenetics: 2 works · 11.4% of their workPublic Health, Environmental and Occupational Health: 1 works · 6.8% of their workEverything else: 4 works · 25.0% of their workPhysical Sciences: 2 works · 11.4% of their workChemistry: 2 works · 11.4% of their workOrganic Chemistry: 2 works · 11.4% of their workLife Sciences: 1 works · 6.8% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 6.8% of their workPharmacology: 1 works · 6.8% of their workTHEIR WORKPer Andersson15works
Life Sciences7%Physical Sciences11%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine956.8%
  2. Everything else425.0%
    1. Chemistry211.4%
    1. Pharmacology, Toxicology and Pharmaceutics16.8%
  1. 1Hematology25% of their works
  2. 2Pulmonary and Respiratory Medicine14% of their works
  3. 3Genetics11% of their works
  4. 4Organic Chemistry11% of their works
  5. 5Public Health, Environmental and Occupational Health7% of their works
  6. 6Pharmacology7% of their works

Research topics

Which keywords describe Per Andersson's research?

The keywords of their largest research topics: BCR-ABL, Imatinib, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Indirubin, Quinazoline and Acute Lymphoblastic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. BCR-ABL111 topic
  2. Imatinib111 topic
  3. Prognostic Factors82 topics
  4. Chronic Lymphocytic Leukemia51 topic
  5. Genomic Aberrations51 topic
  6. Indirubin41 topic
  7. Quinazoline41 topic
  8. Acute Lymphoblastic Leukemia31 topic
  9. Childhood Cancer31 topic
  10. EGFR Mutations31 topic
  11. Targeted Therapy31 topic
  12. Clinical Pharmacy21 topic
  13. Esophageal Motility Disorders21 topic
  14. Gastroesophageal Reflux Disease21 topic
  15. Hyperkalemia21 topic
  16. Pharmaceutical Care21 topic
  17. Renin-Angiotensin-Aldosterone System Inhibitors21 topic

Where does Per Andersson work?

Per Andersson's main affiliation in the publication record is Uppsala University, Sweden.

How many publications and citations does Per Andersson have?

OpenAlex counts 15 works and 46 citations for Per Andersson, an h-index of 4, ranking #4,870,603 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Per Andersson

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Per Andersson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.